KOD
Kodiak Sciences Inc.NASDAQHealthcare$40.63-5.09%ClosedMarket Cap: $2.15B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
13.19
P/S
0.00
EV/EBITDA
-8.16
DCF Value
$2.62
FCF Yield
-6.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-255.4%
ROA
-65.4%
ROIC
-73.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-59.4M | $-56.7M | $-1.04 | — |
| FY 2025 | $0.00 | NaN% | $-234.4M | $-230.0M | $-4.32 | — |
| Q3 2025 | $0.00 | -Infinity% | $-62.4M | $-61.5M | $-1.16 | — |
| Q2 2025 | $0.00 | -Infinity% | $-55.5M | $-54.3M | $-1.03 | — |
| Q1 2025 | $0.00 | -Infinity% | $-57.2M | $-57.5M | $-1.09 | — |
| Q4 2024 | $0.00 | -Infinity% | $-46.2M | $-44.1M | $-0.84 | — |
| FY 2024 | $0.00 | -Infinity% | $-186.8M | $-176.2M | $-3.35 | — |
| Q3 2024 | $0.00 | -Infinity% | $-46.6M | $-43.9M | $-0.84 | — |
| Q2 2024 | $0.00 | -Infinity% | $-48.0M | $-45.1M | $-0.86 | — |
| Q1 2024 | $0.00 | -Infinity% | $-46.1M | $-43.0M | $-0.82 | — |
| Q4 2023 | $0.00 | -Infinity% | $-63.4M | $-59.5M | $-1.13 | — |
| FY 2023 | $0.00 | -Infinity% | $-277.3M | $-260.5M | $-4.97 | — |